CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer
Gastric cancer (GC) is a prevalent malignant cancer characterized by a poor survival rate. The C-type lectin domain family 11 member A (CLEC11A) is part of the C-type lectin superfamily, and its dysregulation has been implicated in the progression of several cancers. The specific role of CLEC11A an...
Main Authors: | Weidan Fang, Dewen Wan, Yi Yu, Ling Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2024-01-01
|
Series: | Biomolecules & Biomedicine |
Subjects: | |
Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/9384 |
Similar Items
-
Identification and characterization of CLEC11A and its derived immune signature in gastric cancer
by: Qing Zheng, et al.
Published: (2024-01-01) -
High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
by: Chengliang Yin, et al.
Published: (2021-03-01) -
ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
by: Biao Fan, et al.
Published: (2021-10-01) -
<i>EGFR</i> Mutation-Harboring Lung Cancer Cells Produce CLEC11A with Endothelial Trophic and Tumor-Promoting Activities
by: Tzu-Yin Lin, et al.
Published: (2022-03-01) -
ASGR1 and Its Enigmatic Relative, CLEC10A
by: J. Kenneth Hoober
Published: (2020-07-01)